Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1115 of 5804
-
Gentler chemo combo shows promise for older leukemia patients
Disease control OngoingThis is a single arm open-label phase 2 trial to study the safety and efficacy of SC Blinatumomab in combination with low-intensity chemotherapy for older or unfit patients with B-ALL.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Pfizer launches early trial of PF-08634404 combo for tough lung cancers
Disease control Recruiting nowThis study is being done to learn more about a new medicine called PF-08634404 and how it works when used with other cancer medicines in people who have advanced solid tumors. An advanced solid tumor is a type of cancer that has spread beyond its original location and cannot be r…
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Ecstasy could ease severe nerve pain in new pilot trial
Symptom relief Recruiting nowThis is a Health Canada regulated internal pilot study designed to assess the feasibility, tolerability, and preliminary efficacy of 3, 4-methylenedioxymethamphetamine hydrochloride capsules-AT for chronic neuropathic pain to inform a larger, fully powered multi-center study. Thi…
Phase: PHASE2 • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Heart pouch showdown: which device best prevents strokes?
Disease control Not yet recruitingClinical investigation with CE-marked medical devices, multicenter, prospective, randomized and controlled. Patients with non-valvular atrial fibrillation at high embolic risk and with at least one high bleeding risk criterion according to the Munich consensus document will be ra…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for kids with rare calcium disease: encaleret trial launches
Disease control Recruiting nowThe overall objective of this study is to evaluate the pharmacokinetics (PK), efficacy, and safety of encaleret in pediatric participants from birth to 17 years of age with ADH1.
Phase: PHASE2, PHASE3 • Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New gel could ease pain and heal wounds for kids with butterfly skin
Symptom relief Recruiting nowThis is a Phase 2, double-blind, randomized, vehicle-controlled study designed to evaluate efficacy, safety, and tolerability of topically applied TCP-25 gel in patients with confirmed DEB or JEB. The study will implement intrasubject randomization, ie, a pair of matching index w…
Phase: PHASE2 • Sponsor: Xinnate AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
New lung transplant method lets patients breathe naturally during surgery
Disease control Not yet recruitingThe goal of this prospective, multicenter, single-arm cohort study is to learn whether a lung transplantation approach that preserves patients' spontaneous breathing during surgery can improve early recovery in adults aged 70 years and older undergoing allogeneic lung transplanta…
Phase: NA • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
AI predicts which cancer patients will develop liver spread
Diagnosis Recruiting nowThis is a prospective, multicenter, observational study designed to validate the predictive accuracy of a pre-developed multimodal deep learning model. The model integrates preoperative contrast-enhanced CT scans, digitized postoperative pathology images, and standard clinical da…
Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Shocking tinnitus away: new brain retraining trial offers hope
Symptom relief Recruiting nowThis study tests whether pairing non-invasive stimulation of the greater occipital nerve (NITESGON) with an attentionally demanding auditory frequency discrimination training task reduces tinnitus loudness and tinnitus-related distress. One hundred adults with chronic tonal tinni…
Phase: NA • Sponsor: University of Dublin, Trinity College • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New cocktail of drugs shows promise for tough bile duct cancer
Disease control Recruiting nowThis study will investigate the safety and effectiveness of a new combination treatment for patients with advanced bile duct cancer. The treatment combines standard chemotherapy drugs (gemcitabine and cisplatin) with two additional medications: adebrelimab and simvastatin. All p…
Phase: PHASE1, PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill could tame eye inflammation without needles
Disease control Recruiting nowThe purpose of this study is to find out the efficacy and safety of oral FXS5626 in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Phase: PHASE2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug APAC aims to prevent blood clots in leg artery patients
Disease control Recruiting nowThe goal of this study is to learn if a new medicine (called antiplatelet and anticoagulant \[APAC\]) can help the body to prevent blood clots and whether APAC is safe and well tolerated in patients with blocked or narrowed arteries in their legs (peripheral arterial occlusive di…
Phase: PHASE2 • Sponsor: Aplagon Oy • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for IBD patients: switching to guselkumab after ustekinumab fails
Disease control Recruiting nowThe SHIFT-IBD Study is being conducted at multiple medical centers across Canada to evaluate how well guselkumab (Tremfya) works for people with inflammatory bowel disease (IBD) who haven't responded well enough to ustekinumab. Patients will begin guselkumab based on their docto…
Sponsor: TIDHI Innovation Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Bedside test may end guesswork in nerve pain treatment
Knowledge-focused Recruiting nowThe goal of this clinical trial is to determine whether quantitative sensory testing (QST) can be used to classify participants into pain sub-groups and predict who will respond best to certain pain treatments in participants with painful peripheral neuropathy. The analgesic eff…
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
AI listens for warning signs of psychosis relapse
Knowledge-focused Recruiting nowThis observational, multinational study assesses the feasibility of speech and self-report data collection across six languages for Artificial Intelligence (AI)-driven relapse risk estimation in psychosis. Over 12 months, patients at risk of relapse and healthy controls will prov…
Sponsor: Philipp Homan • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Sound waves vs. tumors: new registry tracks Non-Surgical breakthrough
Disease control Recruiting nowHistotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of …
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Experimental cell therapy takes on lupus and muscle disease
Disease control Recruiting nowThis is a prospective, single-arm, open-label and dose-escalation investigator initialed study to evaluate LUCAR-G79D in adult subjects with r/r SLE and r/r IIM.
Phase: PHASE1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study tracks Darolutamide's Real-World impact on advanced prostate cancer
Disease control OngoingThis is an international, prospective, open-label, multicenter, multi-cohort, non-interventional observational study designed to describe the real-world effectiveness and safety of darolutamide in combination with androgen deprivation therapy (ADT), with or without docetaxel, in …
Sponsor: Bayer • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Probiotic drink offers hope for coeliac sufferers with persistent gut pain
Symptom relief Recruiting nowCoeliac Disease (CD) is a lifelong autoimmune condition where eating gluten (a protein found in wheat, barley, and rye) causes damage to the small intestine. It affects around 1 in 100 people. Most individuals feel better and their gut heals after switching to a strict gluten-fre…
Phase: NA • Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Can a wearable device keep heart failure patients out of the hospital?
Disease control Recruiting nowThis clinical trial aims to determine whether a ReDS-guided treatment strategy is superior to the current standard of care for adults hospitalized with heart failure. Additionally, the study will evaluate the safety and cost-effectiveness of this approach. The study seeks to ans…
Phase: NA • Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC